Pancreatic Cancer Trial, Completed (NCT02704143)

Pancreatic Cancer Trial, Completed NCT02704143 Sponsor: Changhai Hospital Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT02704143 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Trial results

AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

According to the results reported on ClinicalTrials.gov, this trial enrolled 63 participants, all of whom received a combination of CyberKnife (a type of targeted radiation treatment) and S-1 (an oral chemotherapy medicine). Of the 63 who started, 53 completed the trial and 10 did not. The trial was primarily looking at how many participants were still alive one year after starting treatment, and also tracked a number of other measures including how long it took for the disease to progress, how long participants survived overall, side effects from the radiation, and participants' quality of life. The reported data shows that 46 out of 63 participants were alive at the one-year mark. For the secondary measures, the reported median time before the disease progressed (meaning the point by which half the participants had experienced worsening) was 10.1 months, and the reported median overall survival time was 14.4 months. Regarding side effects from the radiation, 9 participants were reported to have experienced short-term (acute) side effects, and 5 participants were reported to have experienced longer-term (late) side effects, both measured using standard rating criteria. Quality of life was measured using a standard questionnaire scored from 0 to 100; the reported data shows a range of scores across different areas of wellbeing (from around 9.5 to 74.6), though the specific details of which score matched which area of life were not broken down further in the submitted data. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.

View full results on ClinicalTrials.gov ↗ · Read the linked publication on PubMed (PMID 34274393) ↗

These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with locally advanced pancreatic cancer, confirmed by a CT or MRI scan and a tissue biopsy
You have not received any treatment for your pancreatic cancer before the radiation treatment used in this trial (called SBRT)
Your doctors expect you to live for more than 3 months
Your general health and ability to carry out daily activities falls within a specific range on a standard medical scale (a score of 2 or 3 on the ECOG scale — confirm with trial site)
You are 18 years of age or older
Your blood cell counts (including white blood cells, platelets, and red blood cells) are at or above certain minimum levels, as confirmed by a blood test
Your liver and kidney function blood test results are within acceptable ranges for this trial
Your blood clotting ability is within an acceptable range, based on a blood test result
You (or your legal representative) are willing and able to read and sign a consent form agreeing to take part

Who may not be able to join:

You have already had surgery, chemotherapy, or radiation therapy for your pancreatic cancer
There are signs that your cancer has spread to other parts of your body, as shown by scans
You have a medical reason why you cannot receive radiation therapy
Your general health score on the standard medical scale is 0 or 1 (meaning you are relatively well — confirm with trial site)
You are under 18 years of age
Your blood, liver, or kidney test results are outside the acceptable ranges required by the trial
You have active inflammatory bowel disease or a stomach ulcer
You have had bleeding or a hole (perforation) in your digestive system within the last 6 months
You have a serious heart condition classified as stage III or IV heart failure
You are currently pregnant
You are already taking part in another clinical treatment trial at the same time
It was not possible for doctors to place small marker seeds (called fiducials) in your body to help guide the radiation treatment
You (or your legal representative) are not able or willing to sign the consent form

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I found the following past clinical trial relevant to my condition, and wanted to raise it with you. It is no longer recruiting, but I wanted to ask whether similar active trials exist, or whether its results are relevant to my care:

Trial: NCT02704143

Sponsor: Changhai Hospital

Phase: Not Applicable

Status: Completed

Condition: Pancreatic Cancer

More information: https://clinicaltrials.gov/study/NCT02704143

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with locally advanced pancreatic cancer, confirmed by a CT or MRI scan and a tissue biopsy
You have not received any treatment for your pancreatic cancer before the radiation treatment used in this trial (called SBRT)
Your doctors expect you to live for more than 3 months
Your general health and ability to carry out daily activities falls within a specific range on a standard medical scale (a score of 2 or 3 on the ECOG scale — confirm with trial site)
You are 18 years of age or older
Your blood cell counts (including white blood cells, platelets, and red blood cells) are at or above certain minimum levels, as confirmed by a blood test
Your liver and kidney function blood test results are within acceptable ranges for this trial
Your blood clotting ability is within an acceptable range, based on a blood test result
You (or your legal representative) are willing and able to read and sign a consent form agreeing to take part

Who may not be able to join:

You have already had surgery, chemotherapy, or radiation therapy for your pancreatic cancer
There are signs that your cancer has spread to other parts of your body, as shown by scans
You have a medical reason why you cannot receive radiation therapy
Your general health score on the standard medical scale is 0 or 1 (meaning you are relatively well — confirm with trial site)
You are under 18 years of age
Your blood, liver, or kidney test results are outside the acceptable ranges required by the trial
You have active inflammatory bowel disease or a stomach ulcer
You have had bleeding or a hole (perforation) in your digestive system within the last 6 months
You have a serious heart condition classified as stage III or IV heart failure
You are currently pregnant
You are already taking part in another clinical treatment trial at the same time
It was not possible for doctors to place small marker seeds (called fiducials) in your body to help guide the radiation treatment
You (or your legal representative) are not able or willing to sign the consent form

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Completed

Phase

Not Applicable

Sponsor

Changhai Hospital

Registry

ClinicalTrials.gov

Start date

1 February 2016

Est. completion

1 May 2020

Where this trial is recruiting

🇨🇳 China

Primary endpoints

One-year Overall Survival Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov